Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Valence Life Sciences

Founders Eric Roberts



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
The average size of a deal this fund participated in
Portfolio companies 4
Rounds per year 0.90
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 2
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Life Science

Valence Life Sciences is the famous VC, which was founded in 2012. The main department of described VC is located in the New York. The venture was found in North America in United States.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Valence Life Sciences, startups are often financed by Kleiner Perkins, InterWest Partners, Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Kleiner Perkins, InterWest Partners, Wexford Capital. In the next rounds fund is usually obtained by Kleiner Perkins, InterWest Partners, HealthCare Royalty Partners.

The higher amount of exits for fund were in 2015. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2012. Opposing the other organizations, this Valence Life Sciences works on 11 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The fund was created by Eric Roberts. We also calculated 2 valuable employees in our database.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Celator Pharmaceuticals, Invuity For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Valence Life Sciences:
Typical Co-investors
Valence Life Sciences is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Valence Life Sciences:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aimyunion China, Guangdong, Guangzhou
Anjos do Brasil Brazil, São Paulo, Sao Paulo
Chengdu Kaisite Electronic Technology Chengdu, China, Sichuan
Coal Hill Ventures Pennsylvania, Pittsburgh, United States
Focus Holdings -
Global Chance Fund Bayern, Germany, Landshut
Groupe Aeroplan Canada, Montreal, Quebec
Hongzhao Fund China, Futian District, Guangdong Province
Lobb Heng Group China China, Shanghai
Mengxiangzhe Dianying Beijing, Beijing, China
NLG Advisors -
Peach Ventures England, London, United Kingdom
PPG Industries Pennsylvania, Pittsburgh, United States
Shiji Ruiyuan Touzi China, Guangdong Province, Huizhou
TealTech Capital Moscow, Moscow, Russia
Translational Research Institute for Space Health (TRISH) -
UBS Oncology Impact Fund -
Walter Ventures Andalucia, Málaga, Spain
Zhongli Hecai Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Information Technology
Life Science
$15M22 May 2020 San Diego, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Valence Life Sciences?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 29M
Rounds per year 0.90
Peak activity year 2020
Lead investments 1
Follow on index 0.56
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Information Technology
Life Science
$15M22 May 2020 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: